IMMUNOPRECISE ANTIBODIES LTD revenue breakdown overview

IMMUNOPRECISE ANTIBODIES LTD revenue for the last year amounted to 13.87 M EUR, the most of which — 12.75 M EUR — came from its highest performing source at the moment, Antibody Production Project, the year earlier bringing 13.12 M EUR. The greatest contribution to the revenue figure was made by Europe — last year it brought IMMUNOPRECISE ANTIBODIES LTD 6.45 M EUR, and the year before that — 7.13 M EUR.